Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia

Giorgio Diamantis, Marco Scarpa, Paolo Bocus, Stefano Realdon, Carlo Castoro, Ermanno Ancona, Giorgio Battaglia

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Incidence of esophageal cancer (EC) is rising more rapidly in the Western world than that of any other cancer. Despite advances in therapy, more than 50% of patients have incurable disease at the time of presentation. This precludes curative treatment and makes palliative treatment a more realistic option for most of these patients. Dysphagia is the predominant symptom in more than 70% of patients with EC and although several management options have been developed in recent years to palliate this symptom, the optimum management is not established. Self-expanding metal stents (SEMS) are a well-established palliation modality for dysphagia in such patients. Health-related quality of life (HRQoL) is becoming a major issue in the evaluation of any therapeutic or palliative intervention. To date, only a few published studies can be found on Medline examining HRQoL in patients with advanced EC treated with SEMS implantation. The aim of this study was to review the impact on HRQoL of SEMS implantation as palliative treatment in patients with EC. All Medline articles regarding HRQoL in patients with advanced EC, particularly those related to SEMS, were reviewed. In most studies, relief of dysphagia was the only aspect of HRQoL being measured and SEMS implantation was compared with other palliative treatments such as brachytherapy and laser therapy. SEMS insertion provides a swift palliation of dysphagia compared to brachytherapy and no evidence was found to suggest that stent implantation is different to laser treatment in terms of improving dysphagia, recurrent dysphagia and better HRQoL, although SEMS insertion has a better technical success rate and also reduces the number of repea interventions.

Original languageEnglish
Pages (from-to)144-150
Number of pages7
JournalWorld Journal of Gastroenterology
Volume17
Issue number2
DOIs
Publication statusPublished - Jan 14 2011

Fingerprint

Deglutition Disorders
Stents
Quality of Life
Metals
Esophageal Neoplasms
Palliative Care
Brachytherapy
Western World
Laser Therapy
Therapeutics
Lasers
Incidence
Neoplasms

Keywords

  • Esophageal cancer
  • Health-related quality of life
  • Self-expandable metal stents

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia. / Diamantis, Giorgio; Scarpa, Marco; Bocus, Paolo; Realdon, Stefano; Castoro, Carlo; Ancona, Ermanno; Battaglia, Giorgio.

In: World Journal of Gastroenterology, Vol. 17, No. 2, 14.01.2011, p. 144-150.

Research output: Contribution to journalArticle

@article{ddfab8e7285f421d9f75b82438514ef1,
title = "Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia",
abstract = "Incidence of esophageal cancer (EC) is rising more rapidly in the Western world than that of any other cancer. Despite advances in therapy, more than 50{\%} of patients have incurable disease at the time of presentation. This precludes curative treatment and makes palliative treatment a more realistic option for most of these patients. Dysphagia is the predominant symptom in more than 70{\%} of patients with EC and although several management options have been developed in recent years to palliate this symptom, the optimum management is not established. Self-expanding metal stents (SEMS) are a well-established palliation modality for dysphagia in such patients. Health-related quality of life (HRQoL) is becoming a major issue in the evaluation of any therapeutic or palliative intervention. To date, only a few published studies can be found on Medline examining HRQoL in patients with advanced EC treated with SEMS implantation. The aim of this study was to review the impact on HRQoL of SEMS implantation as palliative treatment in patients with EC. All Medline articles regarding HRQoL in patients with advanced EC, particularly those related to SEMS, were reviewed. In most studies, relief of dysphagia was the only aspect of HRQoL being measured and SEMS implantation was compared with other palliative treatments such as brachytherapy and laser therapy. SEMS insertion provides a swift palliation of dysphagia compared to brachytherapy and no evidence was found to suggest that stent implantation is different to laser treatment in terms of improving dysphagia, recurrent dysphagia and better HRQoL, although SEMS insertion has a better technical success rate and also reduces the number of repea interventions.",
keywords = "Esophageal cancer, Health-related quality of life, Self-expandable metal stents",
author = "Giorgio Diamantis and Marco Scarpa and Paolo Bocus and Stefano Realdon and Carlo Castoro and Ermanno Ancona and Giorgio Battaglia",
year = "2011",
month = "1",
day = "14",
doi = "10.3748/wjg.v17.i2.144",
language = "English",
volume = "17",
pages = "144--150",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "2",

}

TY - JOUR

T1 - Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia

AU - Diamantis, Giorgio

AU - Scarpa, Marco

AU - Bocus, Paolo

AU - Realdon, Stefano

AU - Castoro, Carlo

AU - Ancona, Ermanno

AU - Battaglia, Giorgio

PY - 2011/1/14

Y1 - 2011/1/14

N2 - Incidence of esophageal cancer (EC) is rising more rapidly in the Western world than that of any other cancer. Despite advances in therapy, more than 50% of patients have incurable disease at the time of presentation. This precludes curative treatment and makes palliative treatment a more realistic option for most of these patients. Dysphagia is the predominant symptom in more than 70% of patients with EC and although several management options have been developed in recent years to palliate this symptom, the optimum management is not established. Self-expanding metal stents (SEMS) are a well-established palliation modality for dysphagia in such patients. Health-related quality of life (HRQoL) is becoming a major issue in the evaluation of any therapeutic or palliative intervention. To date, only a few published studies can be found on Medline examining HRQoL in patients with advanced EC treated with SEMS implantation. The aim of this study was to review the impact on HRQoL of SEMS implantation as palliative treatment in patients with EC. All Medline articles regarding HRQoL in patients with advanced EC, particularly those related to SEMS, were reviewed. In most studies, relief of dysphagia was the only aspect of HRQoL being measured and SEMS implantation was compared with other palliative treatments such as brachytherapy and laser therapy. SEMS insertion provides a swift palliation of dysphagia compared to brachytherapy and no evidence was found to suggest that stent implantation is different to laser treatment in terms of improving dysphagia, recurrent dysphagia and better HRQoL, although SEMS insertion has a better technical success rate and also reduces the number of repea interventions.

AB - Incidence of esophageal cancer (EC) is rising more rapidly in the Western world than that of any other cancer. Despite advances in therapy, more than 50% of patients have incurable disease at the time of presentation. This precludes curative treatment and makes palliative treatment a more realistic option for most of these patients. Dysphagia is the predominant symptom in more than 70% of patients with EC and although several management options have been developed in recent years to palliate this symptom, the optimum management is not established. Self-expanding metal stents (SEMS) are a well-established palliation modality for dysphagia in such patients. Health-related quality of life (HRQoL) is becoming a major issue in the evaluation of any therapeutic or palliative intervention. To date, only a few published studies can be found on Medline examining HRQoL in patients with advanced EC treated with SEMS implantation. The aim of this study was to review the impact on HRQoL of SEMS implantation as palliative treatment in patients with EC. All Medline articles regarding HRQoL in patients with advanced EC, particularly those related to SEMS, were reviewed. In most studies, relief of dysphagia was the only aspect of HRQoL being measured and SEMS implantation was compared with other palliative treatments such as brachytherapy and laser therapy. SEMS insertion provides a swift palliation of dysphagia compared to brachytherapy and no evidence was found to suggest that stent implantation is different to laser treatment in terms of improving dysphagia, recurrent dysphagia and better HRQoL, although SEMS insertion has a better technical success rate and also reduces the number of repea interventions.

KW - Esophageal cancer

KW - Health-related quality of life

KW - Self-expandable metal stents

UR - http://www.scopus.com/inward/record.url?scp=79955778899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955778899&partnerID=8YFLogxK

U2 - 10.3748/wjg.v17.i2.144

DO - 10.3748/wjg.v17.i2.144

M3 - Article

VL - 17

SP - 144

EP - 150

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 2

ER -